BioPharma Pharma Research
WuXi AppTec Reports First Quarter 2024 Financial Results: Solid Performance with Continued Growth in R&D Services
First Quarter 2024 Financial Highlights: Revenue of RMB 7,982 million, with a slight decrease of 1.8% in non-COVID-19 commercial projects, underscoring ...
April 30, 2024 | Company results
PRISM BioLab and ONO Pharmaceutical Forge Strategic Collaboration to Advance Oncology Drug Development
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein int...
April 26, 2024 | News
GenFleet Therapeutics Secures FDA Approval for Pioneering Phase III KRAS G12C Inhibitor Trial in Colorectal Cancer
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Adm...
April 22, 2024 | News
Teva Validates AJOVY® Efficacy and Safety in China Phase 3 Migraine Trial
AJOVY confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month All critical efficacy endpoints met significanc...
April 15, 2024 | News
NTT Research Foundation Establishes Pioneering Fellowship Program at Harvard to Explore the Physics of Intelligence
NTT Research Foundation funds Fellowship Program in new field of Physics of Intelligence. Field of study bridges computer science, brain science and phy...
April 12, 2024 | News
ACROBiosystems Debuts 3D Organoid Solutions for Biotherapeutic Research
ACROBiosystems has been continuously rolling out a series of innovative organoid-related products. At a range of significant international events, includin...
April 11, 2024 | News
Cure Brain Cancer Foundation Launches Pioneering $575,000 Fellowship to Support Emerging Leaders in Brain Cancer Research
Cure Brain Cancer Foundation proudly unveiled the launch of its groundbreaking 5-Year Guardian Trust Early Career Fellowship, valued at $575,000. The...
April 08, 2024 | News
Grindeks Expands Global Footprint with New Subsidiaries and Innovative Product Pipeline
In a strategic move to broaden its international market presence, Grindeks has successfully established 28 subsidiaries across Eu...
April 03, 2024 | News
Sebastian Arana Discusses Merck's Strategic Expansion in Asia-Pacific Through Innovative Bioprocessing Facility in Daejeon, South Korea
In an illuminating interview with BioPharma APAC, Sebastian Arana, Executive Vice President and Global Head of Process Solutions at Merck, shares insights ...
April 02, 2024 | Interview
Bridge Biotherapeutics Partners with University of Colorado for Cancer Research
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a...
March 27, 2024 | News
AriBio Secures Exclusive $770M Deal for Alzheimer's Drug in China
AriBio Co., Ltd. (AriBio), announces signing of exclusive marketing rights for AR1001, an investigational drug for early Alzheimer’s disease, in Chin...
March 25, 2024 | News
Australia Grants AUD 17M to TB Alliance for Innovative Treatments
The Australian Government, through the Partnerships for a Healthy Region initiative, has announced a new AUD 17 million grant to support work with TB Allia...
March 25, 2024 | News
Lynk Pharmaceuticals Initiates Pivotal Phase III Trial for Groundbreaking Atopic Dermatitis Treatment
Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals"), a clinical-stage innovative drug development company, announced that it...
March 22, 2024 | News
Antengene Advances ATG-022 in Phase II CLINCH Study for Solid Tumors in China and Australia,
Antengene Corporation Limited, a prominent global biopharmaceutical entity focused on the development and commercialization of pion...
March 21, 2024 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
